NURS 6521NURS6521 FINAL EXAM 300 ACTUAL
QUESTIONS AND CORRECT ANSWERS WITH
RATIONALE LATEST UPDATE ALREADY GRADED A+
ASSURED PASS
This comprehensive set of 300 unique multiple-choice questions covers the
essential content areas of NURS 6521 Advanced Pharmacology, organized into ten
distinct sections for focused study. The questions address pharmacokinetics and
pharmacodynamics, cardiovascular and hematologic drugs, endocrine and
metabolic agents, neurologic and psychiatric medications, antimicrobial and anti-
infective therapies, pain management, respiratory pharmacology, women's health
and reproductive medications, and considerations for geriatric and pediatric
populations. Each question is accompanied by the correct answer and a detailed
rationale explaining the underlying pharmacological principles, mechanisms of
action, adverse effects, drug interactions, and clinical implications. This resource
emphasizes critical thinking and clinical application, preparing students to make
safe prescribing decisions, monitor for adverse effects, and provide comprehensive
patient education across diverse patient populations.
Section 1: Pharmacokinetics and Pharmacodynamics (Questions 1-30)
Question 1
A patient is taking a medication that is a prodrug and a substrate for the CYP3A4
enzyme. The prescriber adds a strong inhibitor of CYP3A4. What outcome should
the nurse anticipate?
A. Increased therapeutic efficacy of the prodrug
B. Decreased therapeutic efficacy of the prodrug
C. Increased risk of prodrug toxicity
D. No change in drug levels
Answer: B
,Rationale: Prodrugs require metabolism to become active. Strong inhibition of
CYP3A4 prevents the conversion of the prodrug to its active form, resulting in
reduced therapeutic efficacy. This is the opposite of what would occur with an
active drug, where inhibition would increase toxicity risk.
---
Question 2
A patient has a serum drug level of 50 mcg/mL. The drug's half-life is 2 hours, and
concentrations above 25 mcg/mL are considered toxic. How long will it take for
the blood level to reach the non-toxic range?
A. 1 hour
B. 2 hours
C. 4 hours
D. 6 hours
Answer: B
Rationale: Half-life is the time required for serum concentration to decrease by
50%. After 2 hours, the level would be 25 mcg/mL, which is at the upper limit of
the non-toxic range.
---
Question 3
Which patient would be at greatest risk for drug toxicity due to altered drug
metabolism?
A. A 35-year-old woman with normal liver function
B. A 50-year-old man with cirrhosis of the liver
C. A 28-year-old man with renal impairment
D. A 65-year-old woman with hypertension
Answer: B
Rationale: The liver is the primary site for drug metabolism. Cirrhosis significantly
impairs hepatic function, leading to reduced drug metabolism and increased risk of
toxicity. Patients with liver disease often require dose adjustments.
,---
Question 4
A patient is taking multiple protein-bound medications. Which laboratory finding
is of greatest concern?
A. Low serum albumin
B. Elevated serum creatinine
C. Increased body fat
D. Low serum potassium
Answer: A
Rationale: Low serum albumin reduces protein binding sites, leading to higher free
(active) drug concentrations. This increases the risk of toxicity for highly protein-
bound medications, especially when multiple such drugs are used concurrently.
---
Question 5
Which type of medication prescribed to a pregnant patient is more likely to cross
the placenta and affect the fetus?
A. Highly polar drugs
B. Ionized drugs
C. Lipid-soluble drugs
D. Protein-bound drugs
Answer: C
Rationale: Lipid-soluble drugs cross the placenta more readily because they can
pass through cell membranes. Highly polar, ionized, or protein-bound drugs have
more difficulty crossing the placental barrier.
---
Question 6
A patient is prescribed a narrow-spectrum antibiotic. What is the primary rationale
for choosing a narrow-spectrum agent over a broad-spectrum agent?
, A. Narrow-spectrum drugs are more potent against all bacteria
B. Narrow-spectrum drugs cost less
C. Broad-spectrum drugs create a risk for superinfection
D. Narrow-spectrum drugs have fewer side effects overall
Answer: C
Rationale: Broad-spectrum antibiotics disrupt normal flora and increase the risk of
superinfection, such as Clostridium difficile-associated diarrhea. Narrow-spectrum
antibiotics target specific pathogens, preserving normal flora and reducing this
risk.
---
Question 7
A patient is receiving gentamicin. The nurse should be cautious when
administering other medications that may cause which adverse effects?
A. Ototoxicity or nephrotoxicity
B. Hepatotoxicity or cardiotoxicity
C. Neurotoxicity or dermatotoxicity
D. Gastrointestinal or respiratory toxicity
Answer: A
Rationale: Gentamicin is an aminoglycoside antibiotic known for its potential to
cause both ototoxicity (hearing loss, balance problems) and nephrotoxicity (kidney
damage). Concurrent use of other medications with similar toxicity profiles
increases the risk.
---
Question 8
A patient presents with a serum magnesium level of 10 mg/dL while receiving
magnesium sulfate for eclampsia. The patient is sweating and has a BP of 88/50.
The nurse should interpret these manifestations as indicating:
A. Hypomagnesemia
B. Magnesium sulfate toxicity
C. Normal therapeutic response
QUESTIONS AND CORRECT ANSWERS WITH
RATIONALE LATEST UPDATE ALREADY GRADED A+
ASSURED PASS
This comprehensive set of 300 unique multiple-choice questions covers the
essential content areas of NURS 6521 Advanced Pharmacology, organized into ten
distinct sections for focused study. The questions address pharmacokinetics and
pharmacodynamics, cardiovascular and hematologic drugs, endocrine and
metabolic agents, neurologic and psychiatric medications, antimicrobial and anti-
infective therapies, pain management, respiratory pharmacology, women's health
and reproductive medications, and considerations for geriatric and pediatric
populations. Each question is accompanied by the correct answer and a detailed
rationale explaining the underlying pharmacological principles, mechanisms of
action, adverse effects, drug interactions, and clinical implications. This resource
emphasizes critical thinking and clinical application, preparing students to make
safe prescribing decisions, monitor for adverse effects, and provide comprehensive
patient education across diverse patient populations.
Section 1: Pharmacokinetics and Pharmacodynamics (Questions 1-30)
Question 1
A patient is taking a medication that is a prodrug and a substrate for the CYP3A4
enzyme. The prescriber adds a strong inhibitor of CYP3A4. What outcome should
the nurse anticipate?
A. Increased therapeutic efficacy of the prodrug
B. Decreased therapeutic efficacy of the prodrug
C. Increased risk of prodrug toxicity
D. No change in drug levels
Answer: B
,Rationale: Prodrugs require metabolism to become active. Strong inhibition of
CYP3A4 prevents the conversion of the prodrug to its active form, resulting in
reduced therapeutic efficacy. This is the opposite of what would occur with an
active drug, where inhibition would increase toxicity risk.
---
Question 2
A patient has a serum drug level of 50 mcg/mL. The drug's half-life is 2 hours, and
concentrations above 25 mcg/mL are considered toxic. How long will it take for
the blood level to reach the non-toxic range?
A. 1 hour
B. 2 hours
C. 4 hours
D. 6 hours
Answer: B
Rationale: Half-life is the time required for serum concentration to decrease by
50%. After 2 hours, the level would be 25 mcg/mL, which is at the upper limit of
the non-toxic range.
---
Question 3
Which patient would be at greatest risk for drug toxicity due to altered drug
metabolism?
A. A 35-year-old woman with normal liver function
B. A 50-year-old man with cirrhosis of the liver
C. A 28-year-old man with renal impairment
D. A 65-year-old woman with hypertension
Answer: B
Rationale: The liver is the primary site for drug metabolism. Cirrhosis significantly
impairs hepatic function, leading to reduced drug metabolism and increased risk of
toxicity. Patients with liver disease often require dose adjustments.
,---
Question 4
A patient is taking multiple protein-bound medications. Which laboratory finding
is of greatest concern?
A. Low serum albumin
B. Elevated serum creatinine
C. Increased body fat
D. Low serum potassium
Answer: A
Rationale: Low serum albumin reduces protein binding sites, leading to higher free
(active) drug concentrations. This increases the risk of toxicity for highly protein-
bound medications, especially when multiple such drugs are used concurrently.
---
Question 5
Which type of medication prescribed to a pregnant patient is more likely to cross
the placenta and affect the fetus?
A. Highly polar drugs
B. Ionized drugs
C. Lipid-soluble drugs
D. Protein-bound drugs
Answer: C
Rationale: Lipid-soluble drugs cross the placenta more readily because they can
pass through cell membranes. Highly polar, ionized, or protein-bound drugs have
more difficulty crossing the placental barrier.
---
Question 6
A patient is prescribed a narrow-spectrum antibiotic. What is the primary rationale
for choosing a narrow-spectrum agent over a broad-spectrum agent?
, A. Narrow-spectrum drugs are more potent against all bacteria
B. Narrow-spectrum drugs cost less
C. Broad-spectrum drugs create a risk for superinfection
D. Narrow-spectrum drugs have fewer side effects overall
Answer: C
Rationale: Broad-spectrum antibiotics disrupt normal flora and increase the risk of
superinfection, such as Clostridium difficile-associated diarrhea. Narrow-spectrum
antibiotics target specific pathogens, preserving normal flora and reducing this
risk.
---
Question 7
A patient is receiving gentamicin. The nurse should be cautious when
administering other medications that may cause which adverse effects?
A. Ototoxicity or nephrotoxicity
B. Hepatotoxicity or cardiotoxicity
C. Neurotoxicity or dermatotoxicity
D. Gastrointestinal or respiratory toxicity
Answer: A
Rationale: Gentamicin is an aminoglycoside antibiotic known for its potential to
cause both ototoxicity (hearing loss, balance problems) and nephrotoxicity (kidney
damage). Concurrent use of other medications with similar toxicity profiles
increases the risk.
---
Question 8
A patient presents with a serum magnesium level of 10 mg/dL while receiving
magnesium sulfate for eclampsia. The patient is sweating and has a BP of 88/50.
The nurse should interpret these manifestations as indicating:
A. Hypomagnesemia
B. Magnesium sulfate toxicity
C. Normal therapeutic response
